0002099105-25-000001.txt : 20251204 0002099105-25-000001.hdr.sgml : 20251204 20251203201949 ACCESSION NUMBER: 0002099105-25-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20251204 DATE AS OF CHANGE: 20251203 EFFECTIVENESS DATE: 20251204 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Curative Inc. CENTRAL INDEX KEY: 0002099105 ORGANIZATION NAME: EIN: 000000000 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-565723 FILM NUMBER: 251547976 BUSINESS ADDRESS: STREET 1: 900 CONGRESS STREET 2: SUITE 500 CITY: AUSTIN STATE: TX ZIP: 78701 BUSINESS PHONE: 855-428-7284 MAIL ADDRESS: STREET 1: 900 CONGRESS STREET 2: SUITE 500 CITY: AUSTIN STATE: TX ZIP: 78701 D 1 primary_doc.xml X0708 D LIVE 0002099105 Curative Inc. 900 CONGRESS SUITE 500 AUSTIN TX TEXAS 78701 855-428-7284 NEVADA Snap Genomics Inc. None Corporation true 2020 Frederick Edward Turner 900 Congress Suite 500 Austin TX TEXAS 78701 Executive Officer Director Tami Denise Wilson-Ciranna 900 Congress Suite 500 Austin TX TEXAS 78701 Executive Officer Chief Financial Officer Isaac Turner 900 Congress Suite 500 Austin TX TEXAS 78701 Executive Officer Chief Technology Officer Health Insurance Decline to Disclose 06b false 2025-10-31 false true false 0 199999922 152549994 47449928 false 12 0 0 0 false Curative Inc. Tami Wilson-Ciranna Tami Wilson-Ciranna Chief Financial Officer 2025-11-28